Blood Test Identifies More Treatable Cancers than Tissue Biopsy Alone

In one of the largest clinical studies to ever examine the impact of using a blood test to detect treatable mutations in non-small cell lung cancer (NSCLC), researchers from the Abramson Cancer Center of the University of Pennsylvania found that they could identify significantly more mutations through liquid biopsy instead of a solid tissue biopsy… Continue reading Blood Test Identifies More Treatable Cancers than Tissue Biopsy Alone

Some Lung-Cancer Patients Benefit from Delayed Chemotherapy

Patients with a common form of lung cancer may still benefit from delayed chemotherapy started up to four months after surgery, according to new research from Yale. The study was published online by JAMA Oncology. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined. For patients with non-small-cell… Continue reading Some Lung-Cancer Patients Benefit from Delayed Chemotherapy